While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look ...

Beta-thalassemia is a rare blood disorder caused by a genetic defect in hemoglobin. Several manufacturers are developing novel treatments for the disease, including Vertex, which has partnered ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look ...

The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients ...

From reprogrammed stem cells to next-generation gene editing, 2024 has seen some incredible developments with the potential ...

Thalassemia is a hereditary blood disorder causing anaemia due to reduced haemoglobin production. Early detection, awareness, ...

Investors looking for stocks that can make dramatic gains can find some in the biopharmaceutical industry. Right now, there ...

There are also facilities for prenatal diagnosis of genetic disorders. Selective therapeutic abortion would be possible if the diagnosis of beta-thalassemia is affirmed. Consequently, there is not ...